PredicineHEREDITARY™

25-gene hereditary cancer assay

A CLIA-certified germline genetic assay that identifies an elevated risk for hereditary cancers and uncovers actionable findings.

• Analyze 25 genes to better guide a screening and prevention plan for breast, ovarian, prostate, pancreatic, colorectal, renal, and gastric cancers

• >99% sensitivity and concordance

• CLIA-certified

Sample types

Whole blood

Sample requirements

20ml whole blood

Turnaround time

10 days

Resource

Genelist
FAQ

Features and benefits

Thorough gene analysis

Thorough sequencing of the 25 most relevant genes for common hereditary cancers.

Covers 7 cancers and more

Identifies an elevated risk for 7 hereditary cancers, including but not limited to breast, ovarian, prostate, pancreatic, colorectal, renal, and gastric cancer.

Actionable results

Clinical results that may be used to guide the approach to health and prevention.

Workflow

PredicineCARE workflow

PredicineHEREDITARY is a CLIA-certified test.

Contact us

If you have any questions or need assistance, complete this form and we will respond within 24 hours.